Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Open-market buy Director bought 16,502 shares at $1.44 ($23,763)
  2. 4 Open-market buy President & Chief Exec Officer bought 16,502 shares at $1.44 ($23,763)
  3. 4 Open-market buy Director bought 66,007 shares at $1.44 ($95,050)
  4. 4 Option exercise 10% owner acquired 4,055,157 shares (option exercise)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Exercise or conversion Director acquired 12,500 shares (option exercise)
  8. 4 Open-market buy Chief Operating Officer bought 3,500 shares at $1.51 ($5,285)
  9. 4 Open-market buy President & Chief Exec Officer bought 27,907 shares at $1.44 ($40,186)
  10. 4 Open-market buy Chief Operating Officer bought 30,000 shares at an average $1.44 ($43,050)
  11. 4 Open-market buy President & Chief Exec Officer bought 41,615 shares at an average $1.43 ($59,429)
  12. 4 Open-market buy VP Finance & CAO bought 5,000 shares at $1.42 ($7,100)
  13. 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4/A Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 28 · 551 filings